MoneyWorks4Me

Supriya Lifescience informs about transcript of earnings call

02 Jun 2023 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Supriya Lifescience has informed that it enclosed the transcript of the Earnings call held on Monday, May 29, 2023 at 11.00 am IST to discuss operational and financial performance of the Company for the Fourth Quarter and Year ended of FY 2022-2023 (Q4 & FY23).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..